Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Prokidney Corp (PROK)

Prokidney Corp (PROK)
0.9900 x 1 1.0500 x 12
Post-market by (Cboe BZX)
1.0200 +0.0298 (+3.01%) 04/25/25 [NASDAQ]
0.9900 x 1 1.0500 x 12
Post-market 0.9626 -0.0574 (-5.63%) 17:59 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.9440
Day High
1.0300
Open 1.0000
Previous Close 0.9902 0.9902
Volume 847,500 847,500
Avg Vol 1,348,345 1,348,345
Stochastic %K 71.30% 71.30%
Weighted Alpha -61.25 -61.25
5-Day Change +0.2291 (+28.97%) +0.2291 (+28.97%)
52-Week Range 0.4603 - 4.4400 0.4603 - 4.4400
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 289,830
  • Shares Outstanding, K 292,698
  • Annual Sales, $ 80 K
  • Annual Income, $ -61,190 K
  • EBIT $ -184 M
  • EBITDA $ -178 M
  • 60-Month Beta 1.52
  • Price/Sales 3,505.06
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 661.46% ( -428.64%)
  • Historical Volatility 136.89%
  • IV Percentile 94%
  • IV Rank 45.11%
  • IV High 1,449.21% on 04/15/25
  • IV Low 14.08% on 07/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 36
  • Volume Avg (30-Day) 103
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 202
  • Open Int (30-Day) 524

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.16
  • Number of Estimates 3
  • High Estimate -0.14
  • Low Estimate -0.17
  • Prior Year -0.16
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4603 +121.59%
on 04/09/25
Period Open: 1.0100
1.1800 -13.56%
on 04/15/25
+0.0100 (+0.99%)
since 03/25/25
3-Month
0.4603 +121.59%
on 04/09/25
Period Open: 1.7200
1.7900 -43.02%
on 01/27/25
-0.7000 (-40.70%)
since 01/24/25
52-Week
0.4603 +121.59%
on 04/09/25
Period Open: 2.7100
4.4400 -77.03%
on 05/20/24
-1.6900 (-62.36%)
since 04/25/24

Most Recent Stories

More News
ProKidney Reports Full Year 2024 Financial Results and Business Highlights

PROK : 1.0200 (+3.01%)
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PROK : 1.0200 (+3.01%)
ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

PROK : 1.0200 (+3.01%)
ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

PROK : 1.0200 (+3.01%)
ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

PROK : 1.0200 (+3.01%)
ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2024

PROK : 1.0200 (+3.01%)
ProKidney to Participate in the UBS Virtual Organ Restoration Day

PROK : 1.0200 (+3.01%)
Why Shares of ProKidney Were Dropping Thursday

Two factors led to the stock's slide on Thursday.

PROK : 1.0200 (+3.01%)
Pre-Market Brief: Stocks Mostly Higher As Investors Await U.S. Inflation Data

March S&P 500 futures (ESH23) are trending up +0.32% this morning after three major U.S. benchmark indices finished the regular session higher as market participants awaited U.S. inflation data for further...

BWEN : 1.4900 (-2.61%)
CONN : 0.0975 (-46.40%)
JD-.LN : 78.320 (+0.20%)
ESH23 : 3,957.05s (-0.09%)
PROK : 1.0200 (+3.01%)
STM : 23.28 (-0.26%)
HEPA : 0.2875 (-0.86%)
SHC : 11.15 (-1.28%)
Did This News Just Mark the End of the SPAC Boom?

The most prolific SPAC sponsor just made a big announcement.

DKNG : 33.79 (-1.14%)
LCID : 2.50 (+2.04%)
SPCE : 2.85 (-1.04%)
SOFI : 12.88 (+4.63%)
AKLI : 0.4320 (-0.62%)
PROK : 1.0200 (+3.01%)
IPOF : 10.03 (unch)
IPOD : 10.03 (-0.10%)
OPEN : 0.7637 (-1.65%)
CLOV : 3.43 (-1.15%)

Business Summary

ProKidney LP is a late clinical-stage cellular therapeutics company focused on CKD. The company's lead product candidate includes REACT(TM) is a first-of-its-kind, patented disease-modifying autologous cellular therapy. ProKidney LP, formerly known as Suvretta Holdings Corp. III, is based in WINSTON-SALEM,...

See More

Key Turning Points

3rd Resistance Point 1.1380
2nd Resistance Point 1.0840
1st Resistance Point 1.0520
Last Price 1.0200
1st Support Level 0.9660
2nd Support Level 0.9120
3rd Support Level 0.8800

See More

52-Week High 4.4400
Fibonacci 61.8% 2.9198
Fibonacci 50% 2.4502
Fibonacci 38.2% 1.9805
Last Price 1.0200
52-Week Low 0.4603

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective